112 related articles for article (PubMed ID: 17200107)
1. Elucidation, quantitative refinement, and in vivo utilization of the HOXA13 DNA binding site.
Knosp WM; Saneyoshi C; Shou S; Bächinger HP; Stadler HS
J Biol Chem; 2007 Mar; 282(9):6843-53. PubMed ID: 17200107
[TBL] [Abstract][Full Text] [Related]
2. HOXA13 regulates the expression of bone morphogenetic proteins 2 and 7 to control distal limb morphogenesis.
Knosp WM; Scott V; Bächinger HP; Stadler HS
Development; 2004 Sep; 131(18):4581-92. PubMed ID: 15342482
[TBL] [Abstract][Full Text] [Related]
3. HOXA13 directly regulates EphA6 and EphA7 expression in the genital tubercle vascular endothelia.
Shaut CA; Saneyoshi C; Morgan EA; Knosp WM; Sexton DR; Stadler HS
Dev Dyn; 2007 Apr; 236(4):951-60. PubMed ID: 17304517
[TBL] [Abstract][Full Text] [Related]
4. Hoxd13 and Hoxa13 directly control the expression of the EphA7 Ephrin tyrosine kinase receptor in developing limbs.
Salsi V; Zappavigna V
J Biol Chem; 2006 Jan; 281(4):1992-9. PubMed ID: 16314414
[TBL] [Abstract][Full Text] [Related]
5. Candidate downstream regulated genes of HOX group 13 transcription factors with and without monomeric DNA binding capability.
Williams TM; Williams ME; Kuick R; Misek D; McDonagh K; Hanash S; Innis JW
Dev Biol; 2005 Mar; 279(2):462-80. PubMed ID: 15733672
[TBL] [Abstract][Full Text] [Related]
6. Loss of Bmp7 and Fgf8 signaling in Hoxa13-mutant mice causes hypospadia.
Morgan EA; Nguyen SB; Scott V; Stadler HS
Development; 2003 Jul; 130(14):3095-109. PubMed ID: 12783783
[TBL] [Abstract][Full Text] [Related]
7. A human bone morphogenetic protein antagonist is down-regulated in renal cancer.
Blish KR; Wang W; Willingham MC; Du W; Birse CE; Krishnan SR; Brown JC; Hawkins GA; Garvin AJ; D'Agostino RB; Torti FM; Torti SV
Mol Biol Cell; 2008 Feb; 19(2):457-64. PubMed ID: 18032587
[TBL] [Abstract][Full Text] [Related]
8. HOXA13 Is essential for placental vascular patterning and labyrinth endothelial specification.
Shaut CA; Keene DR; Sorensen LK; Li DY; Stadler HS
PLoS Genet; 2008 May; 4(5):e1000073. PubMed ID: 18483557
[TBL] [Abstract][Full Text] [Related]
9. HOXA13 regulates Aldh1a2 expression in the autopod to facilitate interdigital programmed cell death.
Shou S; Carlson HL; Perez WD; Stadler HS
Dev Dyn; 2013 Jun; 242(6):687-98. PubMed ID: 23553814
[TBL] [Abstract][Full Text] [Related]
10. Survival of Hoxa13 homozygous mutants reveals a novel role in digit patterning and appendicular skeletal development.
Perez WD; Weller CR; Shou S; Stadler HS
Dev Dyn; 2010 Feb; 239(2):446-57. PubMed ID: 20034107
[TBL] [Abstract][Full Text] [Related]
11. Severe limb defects in Hypodactyly mice result from the expression of a novel, mutant HOXA13 protein.
Post LC; Margulies EH; Kuo A; Innis JW
Dev Biol; 2000 Jan; 217(2):290-300. PubMed ID: 10625554
[TBL] [Abstract][Full Text] [Related]
12. Hoxa13 regulates expression of common Hox target genes involved in cartilage development to coordinate the expansion of the autopodal anlage.
Yamamoto S; Uchida Y; Ohtani T; Nozaki E; Yin C; Gotoh Y; Yakushiji-Kaminatsui N; Higashiyama T; Suzuki T; Takemoto T; Shiraishi YI; Kuroiwa A
Dev Growth Differ; 2019 Apr; 61(3):228-251. PubMed ID: 30895612
[TBL] [Abstract][Full Text] [Related]
13. Group 13 HOX proteins interact with the MH2 domain of R-Smads and modulate Smad transcriptional activation functions independent of HOX DNA-binding capability.
Williams TM; Williams ME; Heaton JH; Gelehrter TD; Innis JW
Nucleic Acids Res; 2005; 33(14):4475-84. PubMed ID: 16087734
[TBL] [Abstract][Full Text] [Related]
14. Distal Limb Patterning Requires Modulation of cis-Regulatory Activities by HOX13.
Sheth R; Barozzi I; Langlais D; Osterwalder M; Nemec S; Carlson HL; Stadler HS; Visel A; Drouin J; Kmita M
Cell Rep; 2016 Dec; 17(11):2913-2926. PubMed ID: 27974206
[TBL] [Abstract][Full Text] [Related]
15. The formation of the thumb requires direct modulation of
Bastida MF; Pérez-Gómez R; Trofka A; Zhu J; Rada-Iglesias A; Sheth R; Stadler HS; Mackem S; Ros MA
Proc Natl Acad Sci U S A; 2020 Jan; 117(2):1090-1096. PubMed ID: 31896583
[TBL] [Abstract][Full Text] [Related]
16. A Hoxa13:Cre mouse strain for conditional gene manipulation in developing limb, hindgut, and urogenital system.
Scotti M; Kherdjemil Y; Roux M; Kmita M
Genesis; 2015 Jun; 53(6):366-76. PubMed ID: 25980463
[TBL] [Abstract][Full Text] [Related]
17. Altered Hox expression and increased cell death distinguish Hypodactyly from Hoxa13 null mice.
Post LC; Innis JW
Int J Dev Biol; 1999 Jul; 43(4):287-94. PubMed ID: 10470645
[TBL] [Abstract][Full Text] [Related]
18. Range of HOX/TALE superclass associations and protein domain requirements for HOXA13:MEIS interaction.
Williams TM; Williams ME; Innis JW
Dev Biol; 2005 Jan; 277(2):457-71. PubMed ID: 15617687
[TBL] [Abstract][Full Text] [Related]
19. A genomic approach to the identification and characterization of HOXA13 functional binding elements.
McCabe CD; Innis JW
Nucleic Acids Res; 2005; 33(21):6782-94. PubMed ID: 16321965
[TBL] [Abstract][Full Text] [Related]
20. Polyalanine expansion in HOXA13: three new affected families and the molecular consequences in a mouse model.
Innis JW; Mortlock D; Chen Z; Ludwig M; Williams ME; Williams TM; Doyle CD; Shao Z; Glynn M; Mikulic D; Lehmann K; Mundlos S; Utsch B
Hum Mol Genet; 2004 Nov; 13(22):2841-51. PubMed ID: 15385446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
